August 23, 2001Dynabac Tablets Recalled
IN (SafetyAlerts) - The Food and
Drug Administration (FDA) said today that Eli Lilly and Company is recalling Dynabac
tablets because of a related substance test failure at stability (12 Month).
This is the first public notice of
this Class III
recall issued by the FDA.
RECALL NUMBER, PRODUCT AND
D-268-1, (Rx) Dynabac tablets, delayed release (Dirithromycin) 250 mg, 10 and 60
count, eight various lots
Eli Lilly and Company, Indianapolis, IN
By letter on May 15, 2001
FIRM INITIATED RECALL:
52,060 -60 count
137,832 -10 count
Questions concerning this recall may be directed
to the FDA at 1-888-INFO-FDA.